18 February 2022 : Original article
Impact on Waitlist Outcomes from Changes in the Medical Eligibility of Candidates for Simultaneous Liver-Kidney Transplantation Following Implementation of the 2017 Organ Procurement and Transplantation Network/United Network for Organ Sharing Policy in the United States
Shingo Shimada1ADEF*, Toshihiro Kitajima1BCE, Yukiko Suzuki1BD, Yasutaka Kuno1BD, Tayseer Shamaa1BC, Tommy Ivanics
1BCE, Kelly Collins1DE, Michael Rizzari1BD, Atsushi Yoshida1BD, Marwan Abouljoud1BD, Dilip Moonka2BD, Shunji Nagai1ACE
DOI: 10.12659/AOT.934850
Ann Transplant 2022; 27:e934850
Table 7 Cause of 1-year death in patient who underwent simultaneous liver-kidney transplantation between the eras.
| n (%) | Before the 2017 policyn=102 (68.9) | After the 2017 policyn=46 (31.1) | P value |
|---|---|---|---|
| Graft failure, n (%) | 4 (3.9) | 1 (2.2) | 0.09 |
| Infection, n (%) | 37 (36.3) | 15 (32.6) | |
| Malignancy, n (%) | 6 (5.9) | 1 (2.2) | |
| Cardiovascular disease, n (%) | 23 (22.5) | 6 (13.0) | |
| Respiratory failure, n (%) | 3 (2.9) | 5 (10.9) | |
| Brain hemorrhage, infarction, n (%) | 8 (7.8) | 1 (2.2) | |
| Multi organ failure, n (%) | 7 (6.9) | 8 (17.4) | |
| Others, n (%) | 14 (13.7) | 9 (19.6) | |
| SLK – simultaneous liver-kidney transplantation. | |||